Wako Pure Chemical to Market GNI's Pathway Software in Japan | GenomeWeb
NEW YORK (GenomeWeb News) – GNI, a drug-discovery firm based in Tokyo, has tapped Wako Pure Chemical to market its biopathway imaging and modeling software in Japan, GNI said last week.
 
Beginning in April, Wako will sell GNI’s Cell Illustrator software through its partner agencies in Japan.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.